Global Bio-Clinical Trials 2012 Just Launched in India!

Informations

• Publié par: cphi-conferences-india
• Nombre de lectures: 19
• Langue: English

Extrait

Global Bio-Clinical Trials 2012 Just Launched

in India!

PR Newswire

BANGALORE, India, July 11, 2012

BANGALORE, India

,

July 11, 2012

/PRNewswire/ --

25-28 September, The Lalit Ashok,

Bangalore

Today, more and more countries across the globe are dedicated towards

developing a favourable environment for the growth of biopharmaceutical and

biosimilar products in their respective markets. The Indian regulatory bodies

like the DCGI and the ICMR too are constantly revising their norms and

standards to promote clinical trials, and eventually the growth of biotech

products in the country. This is largely due to the fact that these bio-products

are solutions to some of the most dreaded diseases and require high

manufacturing and marketing investments.

With these developments in the background, CPhI Conferences is launching

Global Bio-Clinical Trials 2012

, a highly anticipated strategic 4-day initiative

(25-28 September,

Bangalore India

) focused on the challenges pertaining to

conduct of clinical trials for the approval of sensitive biopharmaceuticals and

biosimilars drugs. An interactive seminar on 'Emerging Market Regulations -

Brazil

,

China

,

Russia

, LATAM &

Malaysia

' will take place on 25 September, and

an exclusive workshop on PharmacoKinetics/PharmacoDynamics studies on 28

September.

The 2-day conference (26-27 September) will provide solutions to dealing with

the current regulatory challenges and guidelines for robust design of clinical

trials, economic patient recruitment and retention protocols, latest tool and

techniques for clinical data management and medical writing, along with

updates on the latest pharmacovigilance trends.

Eminent speakers like Dr Ragunadarao Digumarti (HOD, Oncology, NIZAMS

Hyderabad), Mr Solomon Yimam (Assistant Director, Clinical research, US FDA),

Mr Scott Laufenberg (Assistant Director(BIMO), US FDA), Dr Arani Chatterjee

(VP, Clinical research, Panacea Biotec), Dr YK Gupta (National Scientific Co-

ordinator, Pharmacovigilance Programme of

India

), Dr Sanjeev Hegde (GM,

Clinical Development, Piramal Healthcare), Dr Goutam Pujari (VP, Clinical

Research Operations, Glenmark Pharmaceuticals), Dr Deven Parmar (CEO &

Medical Director, Karmic Life Sciences), Dr Ajay Gautam (Executive Director

and Head of Emerging Markets, AstraneZeneca ,

China

), Dr Sanish Davis

(Director Clinical Pharmacology in Emerging Markets, MSD), Mr Arjun Roy (Head

CDM & Biometrics, Ranbaxy) among other industry experts, are already on

board providing the latest updates for development of biopharmaceuticals and

biosimilars in their respective organisations.

Global Bio-Clinical Trials 2012 will bring together 100+ regulators, heads of

clinical research, clinical operations & clinical R&D, pharmacovigilance, medical

affairs, clinical aata management and medical doctors from across

biopharmaceutical and biosimilars companies across

India

and the world, to

help increase awareness about the latest developments pertaining to clinical

trials of bio-products. For more details you can log on to

http://www.bioclinicaltrials.com/pr

CPhI India is a UBM brand, and is the largest and most important meeting place

for the Indian pharma industry. Each year CPhI attracts around 850 exhibitors

and 30,000 visitors to the show, providing us with an unrivalled reach to all the

key decision makers in the Indian Pharma industry.

UBM India is a subsidiary of UBM plc, which is the second largest independent

exhibition organiser in the world. It is the largest trade exhibition organiser in

India

, responsible for 26 exhibitions in different locations across the country.

The company is also involved in the organisation of conference programmes

throughout

India

and in the publications of trade journals and magazines. For

further details please visit http://www.ubmindia.in.

For further information please contact:

Ms Asan Bano

Customer Services Executive

CPhI conferences

[phone]

[e-mail]